uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Molecular and Morphological Pathology.
Show others and affiliations
2016 (English)In: Endocrine (Basingstoke), ISSN 1355-008X, E-ISSN 1559-0100, Vol. 53, no 1, 327-330 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2016. Vol. 53, no 1, 327-330 p.
National Category
Endocrinology and Diabetes
Research subject
Pathology
Identifiers
URN: urn:nbn:se:uu:diva-277718DOI: 10.1007/s12020-015-0816-2ISI: 000377934000037PubMedID: 26615593OAI: oai:DiVA.org:uu-277718DiVA: diva2:905494
Funder
Novo Nordisk
Available from: 2016-02-22 Created: 2016-02-22 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

Casar-Borota, Olivera

Search in DiVA

By author/editor
Casar-Borota, Olivera
By organisation
Molecular and Morphological Pathology
In the same journal
Endocrine (Basingstoke)
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 199 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf